Enochian Biosciences Inc. (ENOB)

Name: Enochian Biosciences Inc. (ENOB) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Enochian Biosciences Inc. (ENOB)

Stock Card

$1.56

$0.86 (122.86%)

As on 11-Aug-2023 09:30EDT

Market cap

$31 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.4

Div. Yield

0 %

Enochian Biosciences (ENOB) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.34 High: 1.62

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-12 Mln
ROE

-0.9 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-1.7
Debt to Equity

0
Book Value

$--
EPS

$-6918.4
Face value

--
Shares outstanding

58,283,600

10 Years Aggregate

CFO

$-66.49 Mln

EBITDA

$-172.60 Mln

Net Profit

$-193.97 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Enochian Biosciences (ENOB)	51.5	201.2	30.0	-42.0	-28.7	-17.2	--
BSE Sensex^*	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 11-Aug-2023 | *As on 04-Sep-2026 | #As on 26-Oct-2023

Company	2022	2021	2020	2019	2018	2017	2016
Enochian Biosciences (ENOB)	-85.9	147.1	-41.2	-28.3	47.1	216.7	-61.5
S&P Small-Cap 600	-17.4	25.3	9.6	20.9	-9.7	11.7	24.7
BSE Sensex	4.4	22.0	15.8	14.4	5.9	27.9	1.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Enochian Biosciences (ENOB)	1.6	31.0	0.0	-387,426.8	--	-567853.8	--	0.4
Verona Pharma - ADR	106.9	9,085.1	167.7	-63.1	-24.9	-26.1	--	33.0

Shareholding Pattern

View Details

About Enochian Biosciences (ENOB)

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and... cancer. The company's product pipeline includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a gene therapy curative treatment for HBV. It develops ENOB-DC-11, an allogeneic dendritic cell therapeutic vaccine for solid tumors; ENOB-DC-12-XX, allogeneic dendritic cell therapeutic vaccine for other solid tumors; and ENOB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. Enochian Biosciences, Inc. has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was incorporated in 2017 and is headquartered in Los Angeles, California. Read more

CEO, Director & Member of HBV Scientific Advisory Board

Dr. Mark R. Dybul M.D.
CFO & Corp. Sec.

Ms. Luisa Puche
Headquarters

Los Angeles, CA
Website

https://www.enochianbio.com

FAQs for Enochian Biosciences (ENOB)

What is the current share price of Enochian Biosciences Inc (ENOB) Today?

The share price of Enochian Biosciences Inc (ENOB) is $1.56 (NASDAQ) as of 11-Aug-2023 09:30 EDT. Enochian Biosciences Inc (ENOB) has given a return of -28.68% in the last 3 years.

What is the current PB & PE ratio of Enochian Biosciences Inc (ENOB)?

Since, TTM earnings of Enochian Biosciences Inc (ENOB) is negative, P/E ratio is not available.
The P/B ratio of Enochian Biosciences Inc (ENOB) is 0.45 times as on 23-Jun-2023, a 91 discount to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	-0.90	1.41
2021	-8.74	1.34
2020	-17.84	1.16
2019	-6.81	0.99
2018	-7.98	0.47

What is the 52 Week High and Low of Enochian Biosciences Inc (ENOB)?

The 52-week high and low of Enochian Biosciences Inc (ENOB) are Rs -- and Rs -- as of 04-Sep-2026.

What is the market cap of Enochian Biosciences Inc (ENOB)?

Enochian Biosciences Inc (ENOB) has a market capitalisation of $ 31 Mln as on 23-Jun-2023. As per SEBI classification, it is a Small Cap company.

Should I invest in Enochian Biosciences Inc (ENOB)?

Before investing in Enochian Biosciences Inc (ENOB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.